send to a friend by email
2021-08-17
According to the financial statements of Jerusalem Pharmaceuticals Company for the first half of 2021, Net profit after tax of the period reached 1,080,269 USD Compared with Net profit after tax 1,165,509 USD for 2020, a net decrease in profit of 7.31%.Total assets of the company reached 79,348,546 USD compared with total assets of 77,707,289 USD at the end of year 2020, a net increase of 2.11%.Total liabilities of the company reached 17,609,426 USD compared with total liabilities of 16,066,093 USD at the end of year 2020, a net increase of 9.60%. Net ownership equity of the company reached 61,739,120 USD (Including Non-Controlling Interests of 2,297,240 USD) compared with total owner equity of 61,641,196 USD (Including Non-Controlling Interests of 2,318,984 USD) at the end of year 2020, a net increase of 0.16%.
|
|